This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Academic Hospital Maastricht, Maastricht University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Mike De Leeuw: Innovator in Cartilage Repair
Introduction
Mike De Leeuw is a notable inventor based in Mheer, Netherlands. He has made significant contributions to the field of medical treatment, particularly in methods for improving cartilage repair and preventing cartilage degeneration in joints. His innovative approach has the potential to enhance the quality of life for many individuals suffering from joint-related issues.
Latest Patents
Mike De Leeuw holds a patent for a method aimed at improving cartilage repair and preventing cartilage degeneration in a joint. This invention involves administering a pharmaceutically active agent directly into the fat pad of a joint. The agents used in this method are selected from a variety of categories, including those that stimulate chondrogenic differentiation, inhibit osteogenesis, and provide anti-inflammatory effects. This patent represents a significant advancement in the treatment of cartilage damage.
Career Highlights
Throughout his career, Mike De Leeuw has worked with prestigious institutions such as Maastricht University and Academic Hospital Maastricht. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cartilage repair.
Collaborations
Mike De Leeuw has collaborated with notable colleagues, including Peter Joseph Emans and Lodewijk Willem Van Rhijn. These partnerships have further enriched his research and development efforts in the medical field.
Conclusion
Mike De Leeuw's innovative work in cartilage repair showcases his dedication to advancing medical treatments. His patent and collaborations highlight the importance of research in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile